Bank of America’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12
| Closed | -$60 | – | 7668 |
|
|
2025
Q3 | $60 | Buy |
12
+2
| +20% | +$10 | ﹤0.01% | 7966 |
|
|
2025
Q2 | $26 | Buy |
10
+1
| +11% | +$3 | ﹤0.01% | 8210 |
|
|
2025
Q1 | $25 | Hold |
9
| – | – | ﹤0.01% | 8090 |
|
|
2024
Q4 | $40 | Sell |
9
-16
| -64% | -$80 | ﹤0.01% | 7904 |
|
|
2024
Q3 | $119 | Buy |
25
+19
| +317% | +$100 | ﹤0.01% | 7682 |
|
|
2024
Q2 | $37 | Buy |
+6
| New | +$36 | ﹤0.01% | 7900 |
|
|
2022
Q3 | – | Sell |
-10
| Closed | – | – | 7939 |
|
|
2022
Q2 | $0 | Buy |
+10
| New | +$477 | ﹤0.01% | 8117 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8402 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8333 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8179 |
|
|
2021
Q2 | – | Sell |
-43
| Closed | -$9.21K | – | 7826 |
|
|
2021
Q1 | $12K | Sell |
43
-15
| -26% | -$6K | ﹤0.01% | 6974 |
|
|
2020
Q4 | $21K | Buy |
+58
| New | +$29.9K | ﹤0.01% | 6577 |
|
|
2019
Q3 | – | Sell |
-28
| Closed | -$3K | – | 7315 |
|
|
2019
Q2 | $3K | Buy |
+28
| New | +$2.77K | ﹤0.01% | 6903 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$8K | – | 7178 |
|
|
2018
Q3 | $8K | Buy |
+20
| New | +$7.98K | ﹤0.01% | 6722 |
|
|
2017
Q4 | – | Sell |
-69
| Closed | -$33K | – | 7078 |
|
|
2017
Q3 | $33K | Hold |
69
| – | – | ﹤0.01% | 6108 |
|
|
2017
Q2 | $26K | Buy |
69
+21
| +44% | +$8.04K | ﹤0.01% | 6132 |
|
|
2017
Q1 | $21K | Buy |
48
+35
| +269% | +$14.3K | ﹤0.01% | 6290 |
|
|
2016
Q4 | $4K | Hold |
13
| – | – | ﹤0.01% | 6741 |
|
|
2016
Q3 | $4K | Sell |
13
-7
| -35% | -$3.2K | ﹤0.01% | 6673 |
|
|
2016
Q2 | $20K | Hold |
20
| – | – | ﹤0.01% | 6250 |
|
|
2016
Q1 | $15K | Hold |
20
| – | – | ﹤0.01% | 6244 |
|
|
2015
Q4 | $9K | Sell |
20
-107
| -84% | -$54.4K | ﹤0.01% | 6714 |
|
|
2015
Q3 | $53K | Hold |
127
| – | – | ﹤0.01% | 5933 |
|
|
2015
Q2 | $96K | Hold |
127
| – | – | ﹤0.01% | 5608 |
|
|
2015
Q1 | $129K | Buy |
127
+20
| +19% | +$18K | ﹤0.01% | 5172 |
|
|
2014
Q4 | $91K | Buy |
107
+54
| +102% | +$44.6K | ﹤0.01% | 5954 |
|
|
2014
Q3 | $42K | Sell |
53
-180
| -77% | -$174K | ﹤0.01% | 6617 |
|
|
2014
Q2 | $271K | Hold |
233
| – | – | ﹤0.01% | 5265 |
|
|
2014
Q1 | $281K | Sell |
233
-7
| -3% | -$9.98K | ﹤0.01% | 5126 |
|
|
2013
Q4 | $258K | Buy |
+240
| New | +$344K | ﹤0.01% | 5353 |
|
Bank of America's EVOK Position: Q4 2025 in Review
Bank of America sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 12 shares — an estimated $60 sold.
Bank of America first reported a position in EVOK in Q4 2013 and held it in 27 quarters. The position peaked at $281K in Q1 2014. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.
- Bank of America reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
- Bank of America sold 12 Evoke Pharma shares in Q4 2025, an estimated $60.
- Bank of America first reported a position in Evoke Pharma in Q4 2013 and held it in 27 quarters.
- Bank of America's Evoke Pharma position peaked at $281K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.
Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.